Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

Jarushka Naidoo; Laura C. Cappelli; Patrick M. Forde; Kristen A. Marrone; Evan J. Lipson; Hans J. Hammers; William H. Sharfman; Dung T. Le; Alan N. Baer; Ami A. Shah; Jemima Albayda; Rebecca L. Manno; Uzma Haque; Anna Kristina Gutierrez; Clifton O. Bingham; Julie R. Brahmer

doi:10.1634/theoncologist.2016-0390

Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

Jarushka Naidoo, Laura C. Cappelli, Patrick M. Forde, Kristen A. Marrone, Evan J. Lipson, Hans J. Hammers, William H. Sharfman, Dung T. Le, Alan N. Baer, Ami A. Shah, Jemima Albayda, Rebecca L. Manno, Uzma Haque, Anna Kristina Gutierrez, Clifton O. Bingham, Julie R. Brahmer

Research output: Contribution to journal › Comment/debate › peer-review

58 Scopus citations

Original language	English (US)
Pages (from-to)	627-630
Number of pages	4
Journal	Oncologist
Volume	22
Issue number	6
DOIs	https://doi.org/10.1634/theoncologist.2016-0390
State	Published - Jun 2017

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1634/theoncologist.2016-0390

Cite this

Naidoo, J., Cappelli, L. C., Forde, P. M., Marrone, K. A., Lipson, E. J., Hammers, H. J., Sharfman, W. H., Le, D. T., Baer, A. N., Shah, A. A., Albayda, J., Manno, R. L., Haque, U., Gutierrez, A. K., Bingham, C. O., & Brahmer, J. R. (2017). Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade. Oncologist, 22(6), 627-630. https://doi.org/10.1634/theoncologist.2016-0390

Naidoo, J, Cappelli, LC, Forde, PM, Marrone, KA, Lipson, EJ, Hammers, HJ, Sharfman, WH, Le, DT, Baer, AN, Shah, AA, Albayda, J, Manno, RL, Haque, U, Gutierrez, AK, Bingham, CO & Brahmer, JR 2017, 'Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade', Oncologist, vol. 22, no. 6, pp. 627-630. https://doi.org/10.1634/theoncologist.2016-0390

@article{7d572b9cf27a4b3eaff1d4a225f38773,

title = "Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade",

author = "Jarushka Naidoo and Cappelli, {Laura C.} and Forde, {Patrick M.} and Marrone, {Kristen A.} and Lipson, {Evan J.} and Hammers, {Hans J.} and Sharfman, {William H.} and Le, {Dung T.} and Baer, {Alan N.} and Shah, {Ami A.} and Jemima Albayda and Manno, {Rebecca L.} and Uzma Haque and Gutierrez, {Anna Kristina} and Bingham, {Clifton O.} and Brahmer, {Julie R.}",

note = "Funding Information: We received financial support from P30-AR053503 Core D from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (C.O.B.), NIH grant DE-12354-15A1 (A.N.B.), the Jerome L. Greene Foundation Scholar Award (L.C.C.), and the Jerome L. Greene Foundation Discovery Award (C.O.B. and J.N.).",

year = "2017",

month = jun,

doi = "10.1634/theoncologist.2016-0390",

language = "English (US)",

volume = "22",

pages = "627--630",

journal = "Oncologist",

issn = "1083-7159",

publisher = "AlphaMed Press",

number = "6",

}

TY - JOUR

T1 - Inflammatory arthritis

T2 - A newly recognized adverse event of immune checkpoint blockade

AU - Naidoo, Jarushka

AU - Cappelli, Laura C.

AU - Forde, Patrick M.

AU - Marrone, Kristen A.

AU - Lipson, Evan J.

AU - Hammers, Hans J.

AU - Sharfman, William H.

AU - Le, Dung T.

AU - Baer, Alan N.

AU - Shah, Ami A.

AU - Albayda, Jemima

AU - Manno, Rebecca L.

AU - Haque, Uzma

AU - Gutierrez, Anna Kristina

AU - Bingham, Clifton O.

AU - Brahmer, Julie R.

N1 - Funding Information: We received financial support from P30-AR053503 Core D from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (C.O.B.), NIH grant DE-12354-15A1 (A.N.B.), the Jerome L. Greene Foundation Scholar Award (L.C.C.), and the Jerome L. Greene Foundation Discovery Award (C.O.B. and J.N.).

PY - 2017/6

Y1 - 2017/6

UR - http://www.scopus.com/inward/record.url?scp=85020884329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020884329&partnerID=8YFLogxK

U2 - 10.1634/theoncologist.2016-0390

DO - 10.1634/theoncologist.2016-0390

M3 - Comment/debate

C2 - 28576858

AN - SCOPUS:85020884329

SN - 1083-7159

VL - 22

SP - 627

EP - 630

JO - Oncologist

JF - Oncologist

IS - 6

ER -

Inflammatory arthritis: A newly recognized adverse event of immune checkpoint blockade

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this